Larry J. Strauss
Keine laufenden Positionen mehr
Profil
Mr. Strauss joined the Company as Vice President, Finance and Chief Financial Officer in June 1999.
Mr. Strauss served as Vice President, Operations from October 1997 to May 1999, and Corporate Controller, beginning in February 1996, with CardioGenesis Corporation, which manufactures proprietary medical devices for treating patients suffering from angina.
From 1991 to 1995, Mr. Strauss was Director of Finance for Telik, Inc., a privately-held biotechnology company.
From 1989 to 1990, Mr. Strauss served as Vice President, Finance and Chief Financial Officer of Xoma Corporation, a biotechnology company.
Mr. Strauss earned a BS degree, cum laude, in Mathematics from Claremont Men’s College and an M.S.
degree in Industrial Engineering and Operational Research from the University of California, Berkeley.
Ehemalige bekannte Positionen von Larry J. Strauss
| Unternehmen | Position | Ende |
|---|---|---|
Fusion Medical Technologies, Inc.
 Fusion Medical Technologies, Inc. Medical SpecialtiesHealth Technology Fusion Medical Technologies, Inc. is used to develop, manufactures and market surgical hemostatic products like sutures and topical agents such as sponges which are used to stop bleeding in a variety of surgeries. The Company's product floSeal (R) matrix hemostatic sealant was used to control surgical bleeding. It products were used in a variety of surgical procedures like cardiac, vascular, spinal, ear, nose, throat, head, neck and cranial surgeries. The company marketed its products through direct sales force. It was headquartered in Fremont, CA. | Finanzdirektor/CFO | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Fusion Medical Technologies, Inc.
Fusion Medical Technologies, Inc. Medical SpecialtiesHealth Technology Fusion Medical Technologies, Inc. is used to develop, manufactures and market surgical hemostatic products like sutures and topical agents such as sponges which are used to stop bleeding in a variety of surgeries. The Company's product floSeal (R) matrix hemostatic sealant was used to control surgical bleeding. It products were used in a variety of surgical procedures like cardiac, vascular, spinal, ear, nose, throat, head, neck and cranial surgeries. The company marketed its products through direct sales force. It was headquartered in Fremont, CA. | Health Technology |
